Reline
Payments companies reported to CMS as associated with Reline. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Reline, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Reline
These are the largest totals companies reported as associated with Reline. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Regis Haid | Atlanta, GA | Neurological Surgery | $7,146,882.40 |
| Robert Isaacs | Durham, NC | Neurological Surgery | $2,159,746.83 |
| Tyler Koski | Chicago, IL | Neurological Surgery | $620,111.30 |
| Vincent Traynelis | Chicago, IL | Neurological Surgery | $598,324.24 |
| Rick Sasso | Carmel, IN | Orthopaedic Surgery of The Spine | $595,998.57 |
| K Riew | New York, NY | Orthopaedic Surgery | $591,109.70 |
| Gregory Mundis | La Jolla, CA | Orthopaedic Surgery of The Spine | $502,366.39 |
| Juan Uribe | Phoenix, AZ | Neurological Surgery | $400,764.49 |
| Amer Samdani | Philadelphia, PA | Neurological Surgery | $162,043.49 |
| Burt Yaszay | Seattle, WA | Orthopaedic Surgery | $157,920.24 |
Prescribed Reline?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.